We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current MEDS market cap is 7.2M. The company's latest EPS is USD -14.8082 and P/E is -0.40.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 2.4M | 2.53M | 2.25M | 2.25M | 1.42M |
| Operating Income | -407k | -1.95M | -348k | -345k | -378k |
| Net Income | -563k | -1.3M | -678k | -1.98M | -3.48M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 7.44M | 17.12M | 9.89M | 11.45M | 8.27M |
| Operating Income | 125k | -2.51M | -5.29M | -4.43M | -12.39M |
| Net Income | -284k | -2.54M | -5.32M | -3.91M | -17.84M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 4.69M | 3.71M | 4.04M | 3.75M | 21.65M |
| Total Liabilities | 3.33M | 3.37M | 3.38M | 5.04M | 10.09M |
| Total Equity | 1.36M | 343k | 655k | -1.3M | 11.56M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 5.57M | 9.79M | 5.77M | 3.71M | 12.53M |
| Total Liabilities | 1.43M | 1.11M | 2M | 3.37M | 11.99M |
| Total Equity | 4.14M | 8.68M | 3.77M | 343k | 542k |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -2.76M | -1.53M | -931k | -603k | -1.21M |
| Investing | -313k | -428k | 333k | 282k | 74k |
| Financing | 268k | -35k | 681k | -44k | 71k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 142k | -2.22M | -2.57M | -1.53M | -2.07M |
| Investing | -332k | -38k | -23k | -428k | -276k |
| Financing | 2.19M | 5.3M | -208k | -35k | 1.41M |
| Market Cap | 7.2M |
| Price to Earnings Ratio | -0.40 |
| Price to Sales Ratio | 0.87 |
| Price to Cash Ratio | 47.34 |
| Price to Book Ratio | 13.27 |
| Dividend Yield | 133.89% |
| Shares Outstanding | 1.21M |
| Average Volume (1 week) | 14.3k |
| Average Volume (1 Month) | 28.22k |
| 52 Week Change | 20.56% |
| 52 Week High | 44.56 |
| 52 Week Low | 3.69 |
| Spread (Intraday) | 0.53 (8.36%) |
| Company Name | TRxADE HEALTH Inc |
| Address |
850 new burton road dover, delaware 19904 |
| Website | https://www.trxadehealth.com |
| Industry | drugs and proprietary-whsl (5122) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
